How Will Biosimilars Impact the US?

Raulo Frear, PharmD, general manager of OmedaRx, discusses the ramifications of biosimilars hitting the US market.

Raulo Frear, PharmD, general manager of OmedaRx, discusses the ramifications of biosimilars hitting the US market.

Related Content:

InterviewsBiosimilarsSpecialty Pharmacy
ASHP Discusses Grant Received From American Rescue Plan
Daily Medication Pearl: Umbralisib (Ukoniq)
Pharmacist Medication Insights: Abemaciclib (Verzenio) for Breast Cancer